The Primary Biliary Cirrhosis Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including the rising prevalence of autoimmune diseases, advancements in diagnostic technologies, and an increasing focus on personalized medicine. The demand for effective treatment...